Medicover AB (publ) (OM:MCOV B commences share repurchases on November 6, 2023, under the program mandated by the shareholders in the Annual General Meeting held on April 27, 2023. As per the mandate, the company is authorized to repurchase its own class C shares. The purpose of the repurchase program is to ensure delivery of Performance Shares under the Plan 2021, Plan 2022 and Plan 2023, as well as to secure potential social charges arising as a result of the Plan 2022 and Plan 2023, as applicable.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
161 SEK | +23.28% | +22.71% | +7.26% |
Apr. 26 | Nordic Shares Closed Up Friday; Medicover Series B Climbed Highest | DJ |
Apr. 26 | Transcript : Medicover AB, Q1 2024 Earnings Call, Apr 26, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.26% | 2.2B | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- MCOV B Stock
- News Medicover AB
- Medicover AB (OM: MCOV B) commences an Equity Buyback Plan, under the authorization approved on April 27, 2023.